Tenofovir Emtricitabine
HIV Infection, Pre-exposure Prophylaxis
300/200mg
Intended to relieve viral replication in human immunodeficiency virus infection to support immune stability.
Tenofovir is an antiviral medication used in combination therapies, such as Truvada, to control viral replication. It serves as a key pillar in HIV Management. We currently list 1 product entry for this compound, used by those managing HIV Infection or accessing Pre-exposure Prophylaxis.
HIV Infection, Pre-exposure Prophylaxis
300/200mg
Intended to relieve viral replication in human immunodeficiency virus infection to support immune stability.
Tenofovir is a nucleotide reverse transcriptase inhibitor, a type of antiviral agent that prevents viruses from multiplying in your body. It is rarely used as a standalone treatment. Instead, manufacturers combine it with other active compounds to create targeted antiretroviral therapies.
These combinations are designed to simplify treatment routines. Because it is highly specific to viral enzymes, it does not interfere with the replication of your own cells. This selectivity allows it to remain a fundamental component in long-term treatment strategies.
This medication is primarily indicated for two specific purposes. It is used to lower the amount of HIV in the blood, which helps the immune system function more effectively over time. Additionally, it is used for individuals who require Pre-exposure Prophylaxis to reduce the risk of acquiring HIV.
Both applications rely on consistent use to maintain effective concentrations in your bloodstream. It is not intended to cure viral infections but rather to manage viral activity and reduce transmission risks.
Tenofovir works by locking onto the specific enzyme the HIV virus needs to create new copies of its genetic material. By blocking this enzyme, the medication prevents the virus from producing new, infectious particles. Once the production of new copies stops, the existing viral count in your system can decrease.
Because the virus cannot reproduce, the cumulative viral load remains low. This allows your immune system to avoid further damage and potentially maintain its strength.
Tenofovir is frequently paired with other medications, such as emtricitabine, to improve effectiveness and ease of use. This compound is primarily distributed as a Film-coated tablet. These formulations vary in strength to support different clinical needs, ranging from daily management of existing conditions to preventative regimens.
Choosing the right format often depends on your specific treatment goals and the exact combination therapy your medical provider selects.
Availability is expanding for patients across the Philippines and Indonesia, as well as in other Asian markets including Hong Kong, Taiwan and Vietnam. Patients may compare different brand-name combinations and generic alternatives listed on this page to identify the formulation best suited to their treatment plan. Engaging with a healthcare provider is the standard method for arranging access to these medications and ensuring the correct formulation is selected for your health profile.
Verify that the intended medication is the correct combination for your specific protocol, whether for treatment or prophylaxis. Ensure your provider is aware of your pre-existing conditions, particularly relating to bone density or kidney function, as these systems can be affected by long-term antiviral use.
Common reactions can include digestive discomfort, fatigue, or mild headache as your body adjusts to the therapy. Some users experience changes in kidney markers or bone mineral density over extended periods. Monitoring these metrics is a routine part of clinical follow-up for users of this molecule.
Alcohol, certain herbal supplements, and other medications that impact renal function may alter how your body processes this compound. Disclose all current dietary supplements and other health aids to a medical professional before starting this therapy to avoid unintended accumulation of the active compound.
Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.
This content serves as an educational overview and does not constitute medical advice, diagnosis, or recommendations for treatment. Medication products, branding, and concentrations can differ significantly, and this information may not cover all risks associated with your specific health profile. This page does not authorise clinical application or unsupervised use. You must review the individual product labelling and speak with a healthcare professional when clinical judgement or advice is needed regarding your health.
Jun 16, 2026 ⋅ 7 min read
A plain guide to PrEP in Thailand: what it is, how well it works, where expats and travellers can access it, and how the country's free NHSO programme fits in.
Read guide